SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001607062-17-000372
Filing Date
2017-11-06
Accepted
2017-11-06 16:44:44
Documents
1
Effectiveness Date
2017-11-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A gnbt110617def14a.htm DEFA14A 62726
  Complete submission text file 0001607062-17-000372.txt   63699
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0320
Type: DEFA14A | Act: 34 | File No.: 000-25169 | Film No.: 171179958
SIC: 2834 Pharmaceutical Preparations